OraSure Technologies ROA 2010-2025 | OSUR
Current and historical return on assets (ROA) values for OraSure Technologies (OSUR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| OraSure Technologies ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $-0.05B | $0.45B | -11.26% |
| 2025-03-31 | $-0.03B | $0.46B | -7.07% |
| 2024-12-31 | $-0.02B | $0.48B | -4.47% |
| 2024-09-30 | $0.01B | $0.46B | 2.13% |
| 2024-06-30 | $0.03B | $0.47B | 5.55% |
| 2024-03-31 | $0.02B | $0.47B | 4.72% |
| 2023-12-31 | $0.05B | $0.48B | 11.43% |
| 2023-09-30 | $0.05B | $0.46B | 10.80% |
| 2023-06-30 | $0.04B | $0.45B | 9.84% |
| 2023-03-31 | $0.03B | $0.46B | 6.80% |
| 2022-12-31 | $-0.02B | $0.44B | -3.91% |
| 2022-09-30 | $-0.04B | $0.43B | -9.78% |
| 2022-06-30 | $-0.06B | $0.43B | -14.37% |
| 2022-03-31 | $-0.05B | $0.44B | -10.12% |
| 2021-12-31 | $-0.02B | $0.46B | -4.79% |
| 2021-09-30 | $-0.01B | $0.46B | -2.18% |
| 2021-06-30 | $0.01B | $0.47B | 1.33% |
| 2021-03-31 | $0.00B | $0.46B | -0.68% |
| 2020-12-31 | $-0.01B | $0.45B | -3.42% |
| 2020-09-30 | $-0.01B | $0.44B | -3.66% |
| 2020-06-30 | $0.00B | $0.42B | -0.56% |
| 2020-03-31 | $0.01B | $0.33B | 3.58% |
| 2019-12-31 | $0.02B | $0.35B | 4.80% |
| 2019-09-30 | $0.02B | $0.34B | 7.38% |
| 2019-06-30 | $0.02B | $0.33B | 6.00% |
| 2019-03-31 | $0.02B | $0.32B | 6.17% |
| 2018-12-31 | $0.02B | $0.32B | 6.68% |
| 2018-09-30 | $0.02B | $0.30B | 5.77% |
| 2018-06-30 | $0.02B | $0.29B | 5.19% |
| 2018-03-31 | $0.02B | $0.29B | 5.70% |
| 2017-12-31 | $0.03B | $0.30B | 11.23% |
| 2017-09-30 | $0.03B | $0.28B | 12.23% |
| 2017-06-30 | $0.03B | $0.26B | 13.29% |
| 2017-03-31 | $0.03B | $0.23B | 13.73% |
| 2016-12-31 | $0.02B | $0.21B | 9.50% |
| 2016-09-30 | $0.02B | $0.20B | 8.71% |
| 2016-06-30 | $0.01B | $0.20B | 6.23% |
| 2016-03-31 | $0.01B | $0.19B | 5.33% |
| 2015-12-31 | $0.01B | $0.19B | 4.32% |
| 2015-09-30 | $0.00B | $0.19B | 0.00% |
| 2015-06-30 | $0.00B | $0.18B | 0.00% |
| 2015-03-31 | $0.00B | $0.18B | 0.54% |
| 2014-12-31 | $-0.01B | $0.19B | -2.72% |
| 2014-09-30 | $0.00B | $0.19B | 2.19% |
| 2014-06-30 | $0.00B | $0.18B | 0.56% |
| 2014-03-31 | $-0.01B | $0.17B | -3.94% |
| 2013-12-31 | $-0.01B | $0.18B | -6.13% |
| 2013-09-30 | $-0.02B | $0.18B | -12.69% |
| 2013-06-30 | $-0.02B | $0.17B | -12.37% |
| 2013-03-31 | $-0.02B | $0.18B | -12.66% |
| 2012-12-31 | $-0.02B | $0.19B | -9.40% |
| 2012-09-30 | $-0.01B | $0.20B | -6.26% |
| 2012-06-30 | $-0.01B | $0.13B | -8.78% |
| 2012-03-31 | $-0.01B | $0.13B | -7.24% |
| 2011-12-31 | $-0.01B | $0.13B | -7.33% |
| 2011-09-30 | $-0.01B | $0.12B | -8.23% |
| 2011-06-30 | $-0.01B | $0.12B | -4.95% |
| 2011-03-31 | $-0.01B | $0.12B | -4.10% |
| 2010-12-31 | $0.00B | $0.12B | -3.27% |
| 2010-09-30 | $-0.01B | $0.12B | -4.86% |
| 2010-06-30 | $0.00B | $0.12B | -3.20% |
| 2010-03-31 | $-0.01B | $0.12B | -6.43% |
| 2009-12-31 | $-0.01B | $0.13B | -6.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.242B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.950B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.74 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.46 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| QuidelOrtho (QDEL) | United States | $1.948B | 12.26 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 21.53 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |